Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
Learn more about:
Related Clinical Trial
Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies
Extracorporeal Photopheresis in Sezary Syndrome
Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
AEDV Registry of Primary Cutaneous Lymphoma
Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides
Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients